Cargando…
Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities
Phosphodiesterase 10 is a promising target for the treatment of a series of central nervous system (CNS) diseases. Imbalance between oxidative stress and antioxidant defense systems as a universal condition in neurodegenerative disorders is widely studied as a potential therapy for CNS diseases, suc...
Autores principales: | Li, Jinxuan, Chen, Jing-Yi, Deng, Ya-Lin, Zhou, Qian, Wu, Yinuo, Wu, Deyan, Luo, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962708/ https://www.ncbi.nlm.nih.gov/pubmed/29868568 http://dx.doi.org/10.3389/fchem.2018.00167 |
Ejemplares similares
-
Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
por: Wu, Xu-Nian, et al.
Publicado: (2018) -
Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
por: Zhang, Chen, et al.
Publicado: (2017) -
Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2021) -
Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
por: Wu, Xu-Nian, et al.
Publicado: (2022) -
Design and Microwave Assisted Synthesis of Coumarin Derivatives as PDE Inhibitors
por: Kumbar, Mahadev N., et al.
Publicado: (2016)